Evidence map›Paper›PMID 37542604›Full record

ReviewRheumatology international2023

IgG4-related retroperitoneal fibrosis with acute kidney injury: a case report and literature review.

Liubov Petelytska, Adriana Nikitina, Oksana Tarasenko, Ihor Chechotenko, Dmytro Mykhailov, Vladyslav Kravchenko, Oleg Iaremenko

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liubov PetelytskaDepartment of Internal Medicine #3, Bogomolets National Medical University, T. Shevchenko Boulevard, 13, Kiev, 01601, Ukraine. l.petelytska@gmail.com.ORCID http://orcid.org/0000-0001-8330-8681
Adriana NikitinaDepartment of Internal Medicine #3, Bogomolets National Medical University, T. Shevchenko Boulevard, 13, Kiev, 01601, Ukraine.ORCID http://orcid.org/0000-0002-9058-0226
Oksana TarasenkoThe Therapy Department, Kyiv City Clinical Hospital #3, 26, P. Zaporozhtsia Street, Kiev, 02125, Ukraine.ORCID http://orcid.org/0000-0003-0930-1515
Ihor ChechotenkoUrology Department, Kyiv City Clinical Hospital #3, P. Zaporozhtsia Street, 26, Kiev, 02125, Ukraine.ORCID http://orcid.org/0009-0009-3531-6332
Dmytro MykhailovUrology Department, Kyiv City Clinical Hospital #3, P. Zaporozhtsia Street, 26, Kiev, 02125, Ukraine.ORCID http://orcid.org/0009-0002-0344-0194
Vladyslav KravchenkoO. Bogomolets National Medical University, T. Shevchenko Boulevard, 13, Kiev, 01601, Ukraine.ORCID http://orcid.org/0000-0002-8528-0819
Oleg IaremenkoDepartment of Internal Medicine #3, Bogomolets National Medical University, T. Shevchenko Boulevard, 13, Kiev, 01601, Ukraine.ORCID http://orcid.org/0000-0003-2095-5819
Bogomolets National Medical University · UAKyiv City Clinical Oncology Center · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG4-related retroperitoneal fibrosis is a rare cause of renal dysfunction that usually manifests as obstructive nephropathy (sometimes with extrarenal manifestations). Due to the non-specific symptoms at the onset of the disease and often latent course, special laboratory and instrumental examination methods are usually needed to establish a diagnosis. The article describes a clinical case of a relapse of IgG4-related retroperitoneal fibrosis in a 53-year-old patient, who developed bilateral ureterohydronephrosis with postrenal acute kidney injury after the withdrawal of glucocorticoid therapy. The patient underwent bilateral percutaneous nephrostomy and resumed glucocorticoids at a dose of 30 mg/day. Postobstructive diuresis was 22 L. Treatment resulted in a complete normalization of the creatinine level and transient hypokalemia, which was eliminated with potassium medications. At the final stage of the treatment, bilateral stenting of both ureters was performed with a tapering of glucocorticoids to 5 mg per day with CT control of the retroperitoneal space after 5 months. A clinical case demonstrates that an interruption of glucocorticoid treatment in patients with IgG4-related retroperitoneal fibrosis can lead to ureterohydronephrosis with the development of acute kidney injury. In such cases, stenting of the ureters could be considered an optimal therapeutic option.

Indexed as

Acute Kidney InjuryRetroperitoneal FibrosisGlucocorticoidsHumansImmunoglobulin GMiddle AgedGlucocorticoidsImmunoglobulin GClinical caseGlucocorticoidsHydronephrosisIgG4-related diseaseRetroperitoneal fibrosisUreteral obstruction

Identifiers

PMID37542604
OpenAlexW4385606392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.